PHASEWELL RESEARCH
Live / Allowed — Notice of allowance issued (as of 10 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 02 Apr 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99117717
- Mark type
- Stylized text
- Filed
- 02 Apr 2025
- Published for opposition
- 13 Jan 2026
- Attorney of record
- Ryan Levy
Goods and services
- Class 035 — Advertising and business services: Business consulting, management, and planning services in the field of clinical trials, new clinical trial and study procurement, clinical trial data management on behalf of medical and pharmaceutical companies to assist with clinical research and trials, conducting clinical trials for companies, site management organizations services including research and development services in the field of pharmaceuticals and drug development
- Class 042 — Scientific and technological services: Medical and scientific research, namely, conducting clinical trials for others
Owner
- SCP Clinical Research Intermediate Holdings, LLC, Wilmington, DE, US
- SCP Clinical Research Intermediate Holdings, LLC, Wilmington, DE, US
Prosecution history
- 31 Mar 2026 — TEAS STATEMENT OF USE RECEIVED
- 10 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 13 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 13 Jan 2026 — PUBLISHED FOR OPPOSITION
- 07 Jan 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 11 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 01 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 01 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 01 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 30 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 30 Aug 2025 — NON-FINAL ACTION E-MAILED
- 30 Aug 2025 — NON-FINAL ACTION WRITTEN
- 30 Aug 2025 — ASSIGNED TO EXAMINER
- 11 Jul 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Apr 2025 — APPLICATION FILING RECEIPT MAILED